MINI FUTURE LONG - PACIRA BIOSCIENCES Share Price

Certificat

DE000ME42T25

Market Closed - Börse Stuttgart 20:24:49 30/05/2024 BST
1.18 EUR +10.28% Intraday chart for MINI FUTURE LONG - PACIRA BIOSCIENCES
Current month+32.10%
1 month+30.49%
Date Price Change
30/05/24 1.18 +10.28%
29/05/24 1.07 -6.96%
28/05/24 1.15 +3.60%
27/05/24 1.11 -0.89%
24/05/24 1.12 -4.27%

Delayed Quote Börse Stuttgart

Last update May 30, 2024 at 08:24 pm

More quotes

Static data

Product typeKnock-Out mit Stop Loss
Buy / SellCALL
Underlying PACIRA BIOSCIENCES, INC.
Issuer Morgan Stanley
WKN ME42T2
ISINDE000ME42T25
Date issued 22/11/2023
Strike 17.55 $
Maturity Unlimited
Parity 10 : 1
Emission price 1.01
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 1.68
Lowest since issue 0.74

Company Profile

Pacira BioSciences, Inc. is a holding company for Pacira Pharmaceuticals, Inc. The Company's non-opioid treatments include EXPAREL (bupivacaine liposome injectable suspension), which is a long-acting, local analgesic for postsurgical pain management; ZILRETTA (triamcinolone acetonide extended-release injectable suspension), which is an extended-release, intra-articular (IA), corticosteroid injection indicated for OA knee pain, and Iovera, which is a novel handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. EXPAREL is used across multiple orthopedic procedures, including joint reconstruction, shoulder, spine, extremity procedures, and hip fractures. It is developing interventions to address debilitating conditions involving the sympathetic nervous system, such as cardiac electrical storm, chronic pain. Its clinical development programs include PCRX-201, and pMVL-Based Clinical Program.
Sector
-
More about the company

Ratings for Pacira BioSciences, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Pacira BioSciences, Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
29.26 USD
Average target price
44.9 USD
Spread / Average Target
+53.45%
Consensus